Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-042369
Filing Date
2021-06-22
Accepted
2021-06-22 16:02:08
Documents
2
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3866
2 POA DOCUMENT poa.txt EX-24.3_994733 3879
  Complete submission text file 0001209191-21-042369.txt   9204
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Issuer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105
Business Address
Pestrikova Irina (Reporting) CIK: 0001868216 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37969 | Film No.: 211035179